How to Commercially Scale T-cell Allogeneic Therapies
Summary: In this presentation, Jesse Trekker, PhD, Business Development Director at Catalent Cell & Gene Therapy, discusses an innovative manufacturing methodology and fill/finish approaches to accelerate T-cell therapies to the commercial readiness phase.